John Gribben, MD, DSc, FRCPath, FRCP FMedSci, of Barts and The London School of Medicine and Dentistry, London, UK, chairs a discussion with Anas Younes, MD, of Memorial Sloan Kettering Cancer Center, New York, NY, on the highlights from the first day of the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting.
Discussion topics include advances in targeting the tumor microenvironment through immune checkpoint inhibitors, alone or in combination, as a therapeutic strategy for non-Hodgkin lymphoma; and the efforts and challenges to further understand T-cell and B-cell lymphoma biology and underlying molecular events for the development of personalized medicine.